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MinireviewAlternative Strategies
for Becoming an Insider:
Lessons from the Bacterial World
ers such as the intestinal epithelium and the placental
and blood-brain barriers. It is thought that the ability of
these bacteria to invade non-phagocytic cells plays an
essential role in breaching those natural barriers. Efforts
to identify L. monocytogenes determinants that mediate
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internalization resulted in the characterization of two
related proteins, InlA, also known as internalin, and InlB
(Cossart and Lecuit, 1998). InlA is required for L. mono-
Many microbial pathogens that have sustained long- cytogenes entry into the enterocyte-like intestinal epi-
standing associations with their vertebrate hosts have thelial cell Caco-2, while InlB mediates entry into hepato-
evolved sophisticated strategies to subvert cellular cytes and several endothelial, epithelial, and fibroblast-
functions. These strategies are not accidental but rather like cell lines. Both these proteins are able to mediate
the result of evolutionary forces operating over extended the internalization of coated latex beads, indicating that
periods of time to secure the survival of both the patho- they are not only necessary, but also sufficient to trigger
gen and the host. Therefore, it should not come as a bacterial internalization. InlA and InlB share significant
surprise that our developing understanding of patho- amino acid sequence similarity and belong to a Listeria
gen/host cell interactions is not only uncovering won- protein family with at least five additional members. A
derful biology but also teaching us useful lessons about common feature of this protein family is the presence
the inner workings of the cell. at their amino terminus of a domain composed of a
An essential step in the life cycle of many important varying number of leucine-rich repeats (LRRs). This do-
pathogenic bacteria is their ability to invade cells that main is critical for the stimulation of bacterial entry. It
are normally nonphagocytic. Gaining access to an intra- has been proposed that the composition and number
cellular niche provides bacteria with an environment of the LRRs establishes the receptor specificity of these
permissive for growth, allows them to avoid host de- bacterial ligands which, in turn, determines their individ-
fense mechanisms, or permits them to gain access to ual contribution to bacterial entry into different mamma-
deeper tissues. Although certain cells such as macro- lian cells. Recently, the x-ray crystal structure of the
phages are able to internalize particles of the size of leucine-rich repeats domain of InlB was solved, reveal-
a bacterium, gaining access into nonphagocytic cells ing intriguing features (Marino et al., 1999). The LRRs
requires very specific adaptations. The mechanisms by are arranged in tandem, giving the molecule an elon-
which some pathogenic bacteria enter into host cells is gated and curved shape. Each repeat is composed of
beginning to be understood in some detail. Although a b strand that alternates with an opposing antiparallel
significantly different at first glance, there are clearly helix, and the repeats are connected by coils. The b
common themes among the different strategies utilized strands are highly conserved but the helices are diver-
by different pathogenic bacteria to invade cells. Some gent, exhibiting different register and type. Of note is
bacteria have evolved determinants capable of engag- the presence of an amino terminal z40 amino acid do-
ing cell surface receptors to trigger signaling events that main with two highly solvent-exposed calcium ions.
result in their internalization (Cossart and Lecuit, 1998; These calcium ions do not serve structural purposes;
Isberg et al., 2000). Others have evolved strategies to therefore, it has been proposed that they may be in-
engage the signaling machinery within the cell by “in- volved in InlB-receptor binding. This hypothesis is sup-
jecting” bacterial proteins that directly stimulate cellular ported by the observation that the calcium ions are not
events leading to bacterial uptake (Galan and Zhou, only highly exposed but also incompletely coordinated,
2000). Both strategies ultimately involve the activation leaving as many as five oxygen atoms available for inter-
action with other proteins. Although intriguing, so farof signal transduction pathways to promote actin cy-
there is no evidence to support this interesting model.toskeleton rearrangements that drive bacterial internal-
Signaling for Entry: PI-3 Kinase and Beyondization. A recent paper (Braun et al., 2000) and a paper
The signaling events leading to InlA- and InlB-mediatedpublished in this issue of Cell (Shen et al., 2000) have
entry have been partially characterized (Ireton et al.,provided important insight into the mechanisms by
1996, 1999). The actin cytoskeleton, tyrosine phosphor-which one of these bacteria, Listeria monocytogenes,
ylation, and phosphoinositide (PI) 3-kinase activity areenters into cells.
required for entry through both these pathways. Infec-Internalin and Related Proteins: A Family of Listeria
tion of cells with L. monocytogenes as well as treatmentmonocytogenes Determinants that Mediate
with purified InlB leads to the activation of the PIEntry into Nonphagocytic Cells
3-kinase (p85-p110), the tyrosine phosphorylation of theListeria monocytogenes is a food-borne pathogen that,
adaptor proteins Gab1, Cbl, and Shc, and the formationalthough most often not life-threatening, can occasion-
of a complex between p85-p110 and Gab1. Theseally cause serious illness in immunosuppressed individ-
events are predicted to trigger further downstream sig-uals, pregnant women, and neonates. To cause disease,
naling that eventually leads to bacterial uptake. The na-Listeria must traverse a series of formidable host barri-
ture of these signaling events is not known. However,
they may involve the activation of actin-organizing, small
GTP binding proteins such as Rac1, as this GTPase has* E-mail: jorge.galan@yale.edu
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been shown to act downstream of p85-p110 to mediate receptors for InlB. Braun et al. used affinity chromatog-
raphy to isolate InlB-interacting proteins (Braun et al.,actin cytoskeleton rearrangements in response to cer-
tain stimuli in some cell types. 2000). This approach led to the identification of gC1q-R,
the receptor for the globular head of the complementE-Cadherin, the Receptor for InlA
An affinity chromatography strategy identified E-cad- component C1q. In addition to C1q, this receptor has
been reported to bind multiple ligands such as thrombin,herin as the receptor for InlA (Mengaud et al., 1996).
E-cadherin is a calcium-dependent, cell adhesion mole- vitronectin, and the HIV-transactivator Tat. The signifi-
cance of the promiscuity of binding of this receptorcule that plays an essential role in the formation of inter-
cellular junctions, epithelial cell polarization, and general is not clear. The binding of InlB to gC1q-R is strictly
dependent on the presence of divalent cations. How-maintenance of tissue architecture. E-cadherin is com-
posed of an extracellular region made of five repeated ever, it is not known whether this binding is mediated
by the highly exposed calcium ions observed in theectodomains, a transmembrane segment, and an intra-
cytoplasmic domain that interacts with a group of cy- crystal structure of the InlB LRRs internalization domain.
gC1q-R is ubiquitously expressed in most tissues andtoskeleton-associated proteins called catenins. A series
of mutagenesis and domain swapping experiments have cells, which would be consistent with the observation
that InlB mediates entry into a broad range of cells.mapped a residue (a proline at position 16) that is critical
for InlA binding (Lecuit et al., 1999). Interestingly, mouse The involvement of gC1q-R in InlB-mediated entry is
supported by the observation that antibodies to theE-cadherin has a substitution at this position and there-
fore InlA does not promote bacterial entry into mouse gC1q-R or addition of its ligand, C1q, were able to inhibit
InlB-mediated entry. Furthermore, a cell line expressingcells. This finding may explain the observation that InlA
is dispensable for mouse virulence and might also pro- apparently nonfunctional low levels of gC1q-R and
therefore refractory to InlB-mediated entry was ren-vide the basis for establishing an animal model to assess
the role of InlA in virulence. dered susceptible by transiently expressing high levels
of gC1q-R. The identification of gC1q-R as the InlB re-The mechanisms by which the internalin/E-cadherin
interaction leads to bacterial uptake are not well under- ceptor was surprising, as this receptor does not possess
a transmembrane domain or a consensus site for glyco-stood. Signaling through this receptor to promote actin
cytoskeleton reorganization to drive bacterial internal- sylphosphatylinositol membrane anchoring. Thus, the
mechanism by which gC1q-R associates with the cellization is most likely essential since inhibitors of tyrosine
kinases and PI 3-kinase blocked InlA-mediated entry membrane and subsequently signals for internalization
remains unclear. The possibility of the requirement of a(Ireton et al., 1996). Disruption of the interaction of E-cad-
herin with a- and b-catenins effectively prevented InlA- coreceptor for its signaling function has been proposed.
The identification of the second receptor for InlB re-mediated bacterial entry without disrupting bacterial
binding to the receptor (Lecuit et al., 2000). These results sulted from the characterization of proteins that become
tyrosine phosphorylated after treatment of cells withindicate that the direct association of the receptor with
the actin cytoskeleton is essential for mediating entry. soluble InlB (Shen et al., 2000). Soluble InlB is able to
stimulate signaling events similar to those promotedWhether such association is required to transduce
downstream signaling events or simply to facilitate the by Listeria, including PI-3 kinase activation and protein
tyrosine phosphorylation. An z145 kDa protein that be-progressive apposition of the plasma membrane around
the incoming bacteria is not known. There is an interest- came tyrosine phosphorylated upon treatment of cells
with soluble InlB was identified and shown to corre-ing parallel between InlA-mediated entry and invasin-
mediated entry. Invasin is an unrelated outer membrane spond to the Met tyrosine kinase (Met). Met is a high-
affinity receptor for hepatocyte growth factor (alsoprotein of the enteropathogenic bacteria Yersinia pseu-
dotuberculosis and Yersinia enterocolitica that pro- known as scatter factor). Several properties of Met make
it a logical candidate to be a receptor for InlB. Thesemotes entry by binding to a different set of cell adhesion
molecules, the b1 integrin family of proteins (Isberg et al., include its coupling to p85-p110 activation, its associa-
tion with the adaptor proteins Gab1 and Cbl, and its2000). Like InlA-E-cadherin, invasin-mediated signaling
through b1 integrins is required for entry. However, in distribution in tissues and cells where InlB is thought to
exert its function. The involvement of Met as the InlBcontrast to E-cadherin, mutations that interfere with the
association of b1 integrins to the actin cytoskeleton en- receptor is directly supported by several pieces of evi-
dence: (1) InlB induces responses similar to those in-hance rather than prevent invasin-mediated uptake.
Most likely these mutations facilitate the lateral move- duced by HGF, the natural ligand of Met, such as the
tyrosine phosphorylation of Met, Gab1, and Cbl and thement and the subsequent recruitment and clustering of
the integrin receptors that are necessary to stimulate stimulation of cell scattering; (2) InlB directly binds to
Met through its LRR domain; (3) a cell line expressingsignaling. Invasin-mediated signaling alone, however, is
not sufficient to promote bacterial uptake. In addition, low levels of Met and unable to support InlB-mediated
bacterial uptake was rendered permissive for entry byhigh affinity binding of invasin to multiple integrin recep-
tors is necessary for the bacterial surface to serve as a the expression of high levels of Met; and (4) antibodies
directed to Met or a soluble form of the receptor inhibittemplate for the complete “zippering” of the cell plasma
membrane about the bacterium. Whether the binding of bacterial entry.
The identification of two different receptors for theInlA to the ectodomain of E-cadherin serves a similar
purpose in L. monocytogenes entry is not known. InlB protein raises the question whether there is a func-
tional relationship between Met and gC1q-R or whetherMultiple Receptors for InlB
Two recent papers, one of them in this issue of Cell these receptors work independently. There is no evi-
dence to support or rule out a functional interaction(Shen et al., 2000), report the identification of different
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Multiple Bacterial Ligands and Cellular Receptors
to Breach Different Host Barriers?
Evidence indicates that, in vitro, InlA and InlB mediate
entry into different cells, and therefore, it has been pro-
posed that these bacterial ligands play different roles
during bacterial infection. Mouse infection studies have
suggested that InlB plays an important role in the infec-
tion of hepatocytes (Gaillard et al., 1996). In addition,
the tissue distribution of its receptor Met suggests the
possibility that InlB may also be involved in the ability
of L. monocytogenes to breach the placental barrier and
infect the fetus. Met is expressed in the trophoblast of
the placenta and L. monocytogenes has been observed
to infect the trophoblast of pregnant mice. It is therefore
possible that the ability of L. monocytogenes to breach
the placental barrier and fetal endothelial cells is medi-
ated by InlB/Met interactions.
Investigation of the contribution of InlA to bacterial
infection has been hampered by a lack of a suitable
animal model as mouse E-cadherin does not support
InlA-mediated entry (Lecuit et al., 1999). It has been
hypothesized that InlA mediates entry into intestinal epi-
thelial cells since, at least in vitro, this protein mediates
entry into the intestinal epithelial cell line Caco-2. How-
ever, E-cadherin is only expressed on the basolateral
side of polarized cells and therefore would not be avail-
able for interaction with its bacterial ligand when L.
monocytogenes is in the intestinal lumen. It is possible
that L. monocytogenes breaches the intestinal barrier
through the more permissive M-cells that line the intesti-
Figure 1. Hypothetical Diagram of the Alternative Pathways for Lis- nal epithelium and subsequently gains access to the
teria monocytogenes Entry into Cells
intestinal epithelium through the basolateral side where
As described in the text, it is not yet clear whether gC1qR and c-Met
E-cadherin is expressed. Alternatively, L. monocyto-act as coreceptors or independently.
genes may induce signaling events that may lead to
a transient depolarization of the intestinal epithelium,between these two receptors. However, the lack of a
resulting in the availability of E-cadherin for interactiontransmembrane domain in gC1q-R predicts the require-
with InlA. E-cadherin is also expressed in the choroidment of a coreceptor for transmembrane signaling.
plexus and therefore it is possible that InlA helps L.Therefore, it is possible that such a coreceptor may be
monocytogenes to breach the blood-brain barrier. AMet. An answer to this question would be facilitated
more thorough examination of the tissue distribution ofby the availability of a cell line completely devoid of
the different receptors for InlA and InlB will be requiredboth receptors. Nevertheless, a good start may be the
to obtain a coherent picture of the role of the differentexamination of the expression of Met and gC1q-R in
receptors and bacterial ligands in the pathogenesis ofthe gC1q-R- and Met-defective cell lines used in these
L. monocytogenes infection. In addition, the investiga-studies. This type of analysis could determine whether
tion of the potential role of other internalin-like mole-either of these receptors is sufficient to support InlB-
cules in L. monocytogenes pathogenesis has the poten-mediated uptake.
tial to reveal additional pathways of bacterial entry. TheIt is also possible that InlB can bind these receptors
study of this versatile family of bacterial ligands prom-simultaneously through different domains. The calcium
ises to uncover not only novel therapeutic avenues butdependence of InlB binding argues that binding to
also a better understanding of the function of importantgC1q-R may occur through the exposed calcium ions,
cellular receptors.as suggested by the x-ray crystal structure of the InlB
LRR domain. On the other hand, there is no evidence
Selected Readingthat InlB binding to Met requires calcium, arguing that
InlB binds this receptor through a domain distinct for
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Gaillard, J.L., Jaubert, F., and Berche, P. (1996). J. Exp. Med. 183,for InlB binding to Met, as the elution of the bound
359–369.proteins in their affinity experiments was carried out by
the addition of EDTA (Braun et al., 2000). This approach Galan, J.E., and Zhou, D. (2000). Proc. Natl. Acad. Sci. USA 97,
8754–8761.obviously favors the identification of ligands that require
divalent cations for binding. A hypothetical diagram of Ireton, K., Payrastre, B., Chap, H., Ogawa, W., Sakaue, H., Kasuga,
M., and Cossart, P. (1996). Science 274, 780–782.the signaling pathway is shown in Figure 1.
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